“Why are biosimilars taking so long to catch on?”

In this episode of Pharmland, co-hosts Bradley Nelson and Tom Davies talk with RxBenefits Clinical Services Principal Advisor about a hot topic within the pharmacy industry: biosimilars. The experts explore biosimilars and their  role in the pharmacy landscape, including how they can help mitigate skyrocketing specialty drug costs and why there hasn’t been an uptick in usage the way many experts expected. Tune in as they discuss what exactly a biosimilar is, as well as what the future holds for them and their place in the market.

Guest:

Ruth Opdycke, PharmD, Principal Advisor, Clinical Services

Co-hosts:

Bradley Nelson, PharmD, Vice President, Clinical Services

Tom Davies, PharmD, Vice President, Clinical Products